Walgreens Boots Alliance (NASDAQ:WBA) Issues FY25 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) updated its FY25 earnings guidance on Friday. The company provided EPS guidance of $1.40-$1.80 for the period, compared to the consensus EPS estimate of $1.52. Walgreens Boots Alliance also updated its FY 2025 guidance to 1.400-1.800 EPS.

Walgreens Boots Alliance Stock Up 27.5 %

Shares of NASDAQ WBA opened at $11.76 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. The company has a market cap of $10.15 billion, a P/E ratio of -1.17, a PEG ratio of 1.36 and a beta of 0.64. Walgreens Boots Alliance has a 1 year low of $8.08 and a 1 year high of $24.93. The firm has a 50-day simple moving average of $9.26 and a two-hundred day simple moving average of $9.89.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.66 earnings per share. Research analysts anticipate that Walgreens Boots Alliance will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 8.50%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s payout ratio is currently -9.99%.

Analyst Ratings Changes

WBA has been the subject of several analyst reports. Royal Bank of Canada decreased their price objective on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a research note on Wednesday, December 4th. Barclays raised their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Jefferies Financial Group reduced their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, October 23rd. UBS Group raised their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, October 17th. Finally, Morgan Stanley reduced their target price on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research report on Friday, October 11th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $12.58.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.